您的购物车当前为空
别名 莱莫尼利单抗, MHG-8, MHG8, ARGX-115, ARGX115, ABBV-151, ABBV151
Livmoniplimab(ABBV-151; ARGX-115)是一种抗LRRC32(GARP)/TGFβ1的人源化单克隆抗体,通过阻断LRRC32介导的TGFβ1释放,用于治疗局部晚期或转移性实体瘤。
Livmoniplimab(ABBV-151; ARGX-115)是一种抗LRRC32(GARP)/TGFβ1的人源化单克隆抗体,通过阻断LRRC32介导的TGFβ1释放,用于治疗局部晚期或转移性实体瘤。
| 规格 | 价格 | 库存 | 数量 |
|---|---|---|---|
| 1 mg | ¥ 2,570 | In stock | |
| 5 mg | ¥ 5,880 | In stock | |
| 10 mg | ¥ 7,930 | In stock | |
| 25 mg | ¥ 11,800 | In stock |
Livmoniplimab 相关产品
| 产品描述 | Livmoniplimab (ABBV-151; ARGX-115) is a humanised monoclonal antibody targeting LRRC32 (GARP)/TGFβ1, which blocks TGFβ1 release mediated by LRRC32, for the treatment of locally advanced or metastatic solid tumours. |
| 体内活性 | 方法: |
| 别名 | 莱莫尼利单抗, MHG-8, MHG8, ARGX-115, ARGX115, ABBV-151, ABBV151 |
| CAS No. | 2412004-88-5 |
| 颜色 | Transparent |
| 物理性状 | Liquid |
| 存储 | store at low temperature | -20°C for 1 year | Shipping with blue ice/Shipping at ambient temperature. |
评论内容